These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 9771838
1. Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection. Pearse MJ, Witort E, Mottram P, Han W, Murray-Segal L, Romanella M, Salvaris E, Shinkel TA, Goodman DJ, d'Apice AJ. Transplantation; 1998 Sep 27; 66(6):748-54. PubMed ID: 9771838 [Abstract] [Full Text] [Related]
2. Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice. Gock H, Salvaris E, Murray-Segal L, Mottram P, Han W, Pearse MJ, Goodman DJ, Cowan PJ, d'Apice AJ. Xenotransplantation; 2000 Nov 27; 7(4):237-46. PubMed ID: 11081758 [Abstract] [Full Text] [Related]
3. Naturally acquired anti-alpha Gal antibodies in a murine allograft model similar to delayed xenograft rejection. Salvaris E, Gock H, Han W, Murray-Segal L, Barlow H, Mottram P, Pearse M, Cowan P, Goodman D, d'Apice AJ. Xenotransplantation; 2000 Feb 27; 7(1):42-7. PubMed ID: 10809056 [Abstract] [Full Text] [Related]
4. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice. Chong AS, Ma L, Yin D, Shen J, Blinder L, XiuLong X, Williams JW, Byrne G, Diamond LE, Logan JS. Xenotransplantation; 2000 Nov 27; 7(4):275-83. PubMed ID: 11081762 [Abstract] [Full Text] [Related]
5. A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice. McKenzie IF, Li YQ, Patton K, Thall AD, Sandrin MS. Transplantation; 1998 Sep 27; 66(6):754-63. PubMed ID: 9771839 [Abstract] [Full Text] [Related]
6. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. Yin DP, Sankary HN, Ma LL, Shen J, Qin Y, Blinder L, Williams JW, Chong AS. Transplantation; 2001 May 27; 71(10):1385-9. PubMed ID: 11391223 [Abstract] [Full Text] [Related]
7. Decay-accelerating factor prevents acute humoral rejection induced by low levels of anti-alphaGal natural antibodies. Shimizu I, Smith NR, Zhao G, Medof E, Sykes M. Transplantation; 2006 Jan 15; 81(1):95-100. PubMed ID: 16421483 [Abstract] [Full Text] [Related]
8. Effect of αGal on corneal xenotransplantation in a mouse model. Choi HJ, Kim MK, Lee HJ, Jeong SH, Kang HJ, Park CS, Park CG, Joon Kim S, Wee WR. Xenotransplantation; 2011 Jan 15; 18(3):176-82. PubMed ID: 21696447 [Abstract] [Full Text] [Related]
9. The resistance of delayed xenograft rejection to alpha(1,3)-galactosyltransferase gene inactivation and CD4 depletion in a mouse-to-rat model. Hansen AB, Kirkeby S, Aasted B, Dahl K, Hansen AK, Dieperink H, Svendsen M, Kemp E, Buschard K, D'Apice AJ. APMIS; 2003 Nov 15; 111(11):1019-26. PubMed ID: 14629268 [Abstract] [Full Text] [Related]
10. Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Chong A, Blinder L, Ma L, Yin D, Shen J, Williams JW, Byrne G, Schwarz A, Diamond LS, Logan JE. Transpl Immunol; 2000 Jun 15; 8(2):129-37. PubMed ID: 11005319 [Abstract] [Full Text] [Related]
11. Anti-alpha1,3-galactose-mediated hyperacute rejection of vascularized transplants in a small animal model. Gock H, Salvaris E, Han W, Murray-Segal L, Mottram P, Cowan P, Goodman DJ, d'Apice AJ. Transplant Proc; 2000 Nov 15; 32(7):2075. PubMed ID: 11120073 [No Abstract] [Full Text] [Related]
12. In Contrast to Anti-C5 Therapy, Cobra Venom Factor Does Not Prevent Rejection of Xenogeneic Cartilage in Mice. Brokaw JL, Costa C. Transplant Proc; 2015 Oct 15; 47(8):2397-9. PubMed ID: 26518939 [Abstract] [Full Text] [Related]
13. Gal mismatch alone causes skin graft rejection in mice. Gock H, Murray-Segal L, Salvaris E, Cowan PJ, D'Apice AJ. Transplantation; 2002 Sep 15; 74(5):637-45. PubMed ID: 12352879 [Abstract] [Full Text] [Related]
14. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Kuwaki K, Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM, Lancos CJ, Prabharasuth DD, Cheng J, Moran K, Hisashi Y, Mueller N, Yamada K, Greenstein JL, Hawley RJ, Patience C, Awwad M, Fishman JA, Robson SC, Schuurman HJ, Sachs DH, Cooper DK. Nat Med; 2005 Jan 15; 11(1):29-31. PubMed ID: 15619628 [Abstract] [Full Text] [Related]
15. Anti-Gal antibody-mediated skin graft rejection requires a threshold level of Gal expression. Murray-Segal L, Gock H, Cowan PJ, d'Apice AJ. Xenotransplantation; 2008 Feb 15; 15(1):20-6. PubMed ID: 18333910 [Abstract] [Full Text] [Related]
16. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. Xu H, Yin D, Naziruddin B, Chen L, Stark A, Wei Y, Lei Y, Shen J, Logan JS, Byrne GW, Chong AS. J Immunol; 2003 Feb 01; 170(3):1531-9. PubMed ID: 12538718 [Abstract] [Full Text] [Related]
17. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review). Huai G, Qi P, Yang H, Wang Y. Int J Mol Med; 2016 Jan 01; 37(1):11-20. PubMed ID: 26531137 [Abstract] [Full Text] [Related]
18. Delayed rejection of porcine cartilage is averted by transgenic expression of alpha1,2-fucosyltransferase. Costa C, Brokaw JL, Wang Y, Fodor WL. FASEB J; 2003 Jan 01; 17(1):109-11. PubMed ID: 12475900 [Abstract] [Full Text] [Related]